The IDx-DR device uses artificial intelligence software to analyze digital images of the eye and determine whether patients have more than mild diabetic retinopathy without a clinician to interpret the image or results—meaning providers who are not normally familiar with eye care, such as primary care physicians, can use the device.
Despite overall increases in U.S. life expectancy over the last two decades, in some states, the odds of dying young have actually increased, according to study published Tuesday in JAMA.
The New York pilot program, approved Monday, is designed to encourage ED doctors to prescribe opioid alternatives for pain management, in today's bite-sized hospital and health industry news from Michigan, New York, and Ohio.
When you're faced with a difficult problem, it's common to try and brainstorm potential answers, but writing for Harvard Business Review, Hal Gregersen—executive director of the MIT Leadership Center—says you should brainstorm questions instead.
Bloomberg examines a business strategy reportedly by Todd Smith, chair and CEO of Novum Pharma, and Benjamin Bove, an officer at Novum, at four pharmaceutical companies that seemingly led to major price hikes for some prescription drugs—though Novum says the approach is a "patient-access-centered model" that lowers prices for consumers.
President Trump says he would consider having the United States join the Trans-Pacific Partnership, a trade deal with important implications for health care, "if the deal were substantially better than the deal offered to [former President Barack] Obama."
U.S. News & World Report says a new effort to add patient experience ratings to its physician profile pages is intended to help consumers "compare physicians and … make more informed health care decisions."
